Fig. 4.

Timeline of Patient Data and Trial Openings. In Fig. 4, data about patient enrollment were compared to the timeline of trial openings and closures to better characterize how the trials landscape evolved. It is shown that, after the only month where recorded enrollment was 0 patients, the Gloriosa (Platinum sensitive recurrent ovarian) and FIERCE (early stage endometrial) trials were opened. Trial enrollment steadily increased with these openings, up until the point of total employee turnover.